Albania AKBPM Medical Device Registry Teardown: Manufacturers & LTRs
A data-driven teardown of Albania's AKBPM register. Analyze the risk-class split, category mix, manufacturer landscape, and distributor concentration.
Executive Summary
We are scoping Albania for Southeast-Europe expansion: how many medical devices are on the AKBPM register, what is the class and category mix, which manufacturers dominate, and which local distributors already hold the most registrations (and thus control channel access)? How does this impact our regulatory and distribution strategy?
According to our database analysis of the official AKBPM National Register of Medical Devices (snapshot dated November 2025), the register contains 25,436 device records. However, a major data quality caveat exists: only 12,637 records (~49.7%) contain populated classification and applicant metadata, while 12,800 records (~50.3%) are completely unpopulated. Within the populated subset:
- Risk Classes: IVDs represent the largest category with 3,144 records, followed by Class I (3,004), Class IIa (2,936), Class IIb (1,535), and Class III (951).
- Categories: Dominated by Dental Devices (1,903), Single-use Devices (1,567), and In Vitro Diagnostics (2,230 combined).
- Manufacturers: Multinationals dominate the registry, particularly in IVDs and dental technology. The leading manufacturers are Roche Diagnostics (~285 records across address variants), Abbott (~140), Ivoclar Vivadent (82), Zarys International Group (80), Medtronic (72), and Biomerieux (59).
The local distribution channel in Albania is highly consolidated among a small circle of local representatives. Out of 721 unique local applicants, the top 7 players—O.E.S DISTRIMED (684), GREEMED (499), Evita (464), TRIMED (370), MONTAL (357), BIOMETRIC ALBANIA (350), and the Pegasus group (~664 combined)—hold 3,388 registrations, representing 26.8% of populated records (the subset that carries applicant metadata). For new entrants, this concentration signifies that a handful of local distributors hold a dominant grip on market access, making the choice of an Authorized Representative a highly strategic decision.
Introduction to Albania's Medical Device Market and Regulator
Albania, located in the Western Balkans, is an EU-accession candidate country with a population of approximately 2.8 million. The country's medical device and healthcare market is almost entirely dependent on imports (exceeding 95% of total consumption by value). The primary purchaser of medical equipment and clinical consumables is the public sector, funded via the Compulsory Healthcare Insurance Fund (FSDKSH) through competitive public tenders.
The regulatory authority responsible for medical devices is the Agjencia Kombëtare e Barnave dhe Pajisjeve Mjekësore (AKBPM) (National Agency for Medicines and Medical Devices), operating under the Ministry of Health and Social Protection. Established to ensure that all medicines and medical devices commercialized in Albania meet strict safety, quality, and efficacy criteria, AKBPM enforces a mandatory registry before importation is permitted.
For foreign manufacturers, Albania is a classic "CE-reliance" market. Since Albania is aligning its national legislation with the EU acquis, the registration process heavily relies on the device holding a valid European CE mark. Below, we present a quantitative teardown of the 25,436 records in the AKBPM registry to provide market-entry intelligence for Southeast Europe, completing our Western-Balkans coverage alongside the Serbia ALIMS medical device register analysis, the North Macedonia MALMED medical device registry teardown, and the Montenegro CINMED medical device register analysis.
The Legal Framework: Law 89/2014 and Order 360/2016
The registration and commercialization of medical devices in Albania are governed by a specific statutory hierarchy:
- Law No. 89/2014 "On Medical Devices": The primary legislative act, which transposes the principles of the legacy EU Medical Device Directive (MDD 93/42/EEC) and Active Implantable Medical Devices Directive (AIMDD 90/385/EEC). It establishes the mandate for AKBPM to run the national registry and outlines the classification categories (Class I, IIa, IIb, III, and IVDs).
- Order No. 360 of 22.08.2016: Issued by the Ministry of Health, this order defines the administrative procedures, dossier requirements, timelines, and fees for registering devices. It was updated by Order No. 734 of 18.10.2019 to streamline digital submissions.
- CE Mark Mandate: All Class IIa, IIb, III, and active devices must have a valid CE certificate issued by an EU Notified Body. For Class I devices (non-sterile, non-measuring), a Declaration of Conformity is required.
- Varying Timelines: Under Order 360, Class I registrations are processed via a fast-track 5-day timeline, while Class IIa, IIb, and III devices require up to 30 days for desk review.
- Validity: The registry listing is valid for exactly 5 years, or until the underlying CE certificate expires, whichever is earlier.
The Electronic Transition
Historically, AKBPM operated a paper-based filing system, leading to significant delays and lost documentation. The implementation of the online registration module via the e-Albania portal has digitized the workflow. While it has improved review efficiency, it has also highlighted metadata gaps from legacy paper files that were migrated without complete risk-class or manufacturer indexing. This transition has also allowed customs authorities to perform automated electronic sweeps, immediately flagging imported shipments whose product codes do not match an active registry listing.
Database Quality Caveat: The Unpopulated Metadata Gap
Before analyzing the data, it is crucial to address the completeness of the AKBPM register. Of the 25,436 rows in the registry, the fill rate for key metadata fields is exactly 49.7%:
- Class (Klasa) Field: 12,634 populated rows (49.67%)
- Category Field: 12,637 populated rows (49.68%)
- Manufacturer (Prodhuesi) Field: 12,645 populated rows (49.71%)
- Local Applicant Field: 12,645 populated rows (49.71%)
- Unpopulated / None Rows: 12,801 rows (50.33%)
This means that half of the database represents historical, migrated, or poorly indexed entries that lack risk-class and applicant classifications. This data quality gap is common in developing registries transitioning from paper-based tracking to digital portals. When evaluating market sizing or competitor landscapes in Albania, researchers should always base their calculations on the 12,637 populated rows and explicitly state this denominator.
Detailed Analysis of the Populated Registry
By analyzing the 12,637 populated records, we can map the risk classification, clinical categories, and manufacturer landscape.
1. Risk-Class Distribution (Klasa)
To analyze the risk classes, we normalized the raw database fields to clean up spelling variations and typos (e.g., merging "Klasa IIa", "lla", and "Iia" into a single Class IIa count):
| Cleaned Risk Class | Raw Database Matches | Normalized Count | Percentage of Populated Subset |
|---|---|---|---|
| In Vitro (IVD) | In vitro (1,629), In Vitro (1,515) |
3,144 | 24.9% |
| Class I (Low) | Klasa I (1,799), l (516), I (479), Is (210) |
3,004 | 23.8% |
| Class IIa (Medium-Low) | Klasa IIa (1,929), lla (633), Iia (374) |
2,936 | 23.2% |
| Class IIb (Medium-High) | Klasa IIb (936), llb (342), IIb (257) |
1,535 | 12.1% |
| Class III (High) | Klasa III (727), III (224) |
951 | 7.5% |
| Other / Minor typos | Various non-standard strings | 1,067 | 8.5% |
| Total Populated | 12,637 | 100.0% |
Albania AKBPM Risk Class Split (Top 3):
IVD: [=========================] 3,144
Class I: [========================] 3,004
Class IIa: [=======================] 2,936
IVDs represent the single largest risk segment in the populated database, accounting for 24.9% of all listings. Together with Class I and Class IIa devices, low-to-moderate risk technologies make up 71.9% of the populated registry. High-risk Class III devices (such as cardiovascular stents, orthopedic implants, and pacemakers) represent a smaller slice of 7.5%, reflecting the specialized nature and smaller target market for advanced surgical interventions in Albania.
2. Clinical Category Breakdown
Parsing the kategoria_e_pajisjes_mjekesore field reveals the leading categories of technology registered with AKBPM:
| Rank | Category Name (Albanian) | Category Description | Active Listings | Percentage of Populated |
|---|---|---|---|---|
| 1 | Tjeter |
Other (Generic device categories) | 2,349 | 18.6% |
| 2 | Pajisje dentare |
Dental Equipment & Consumables | 1,903 | 15.1% |
| 3 | Pajisje nje perdorimeshe |
Single-use / Disposable Supplies | 1,567 | 12.4% |
| 4 | Pajisje te diagnostifikimit |
In Vitro Diagnostic Systems (Variant A) | 1,328 | 10.5% |
| 5 | Pajisje te diagnostikimit |
In Vitro Diagnostic Systems (Variant B) | 902 | 7.1% |
| 6 | Produkte per institucione |
Hospital & Healthcare Institution Products | 569 | 4.5% |
| 7 | Instrumenta shumeperdorimeshe |
Reusable Surgical Instruments | 540 | 4.3% |
| 8 | Pajisje te implantueshme jo aktive |
Non-active Implants (Screws, Plates) | 484 | 3.8% |
| 9 | Pajisje elektromekanike |
Electromechanical Equipment (Monitors) | 467 | 3.7% |
| 10 | Pajisje te implantueshme aktive |
Active Implantable Devices (pacemakers, infusion pumps) | 294 | 2.3% |
The high volume of Dental Devices (1,903 listings, 15.1%) is a unique characteristic of the Albanian registry. Albania has developed a substantial medical tourism sector for dental procedures (clinics in Tirana offering implants and veneers to Italian and Greek patients), driving high private-market demand for premium dental implants, resins, and equipment.
The Manufacturer Landscape: Multinationals & Specialized Consumables
Who supplies the Albanian medical device market? The manufacturer names (prodhuesi) listed in the populated database are dominated by Western multinationals and large-scale consumable suppliers:
- Roche Diagnostics (~285 records): Roche is the leading supplier, registered under three main address variants (Mannheim, Germany). Their registrations cover clinical chemistry, immunology, and molecular diagnostic platforms.
- Abbott (~140 records): Abbott Laboratories (registered via Abbott Germany and Abbott Ireland) holds a strong position, focusing on immunoassay reagents, point-of-care diagnostics, and rapid testing kits.
- Ivoclar Vivadent AG (82 records): Based in Liechtenstein, Ivoclar is a global leader in dental technology. Their high ranking confirms the strength of Albania’s private dental clinic sector.
- Zarys International Group (80 records): A Polish manufacturer specialized in disposable surgical and clinical consumables (syringes, wound care, basic tubing).
- Medtronic, Inc. (72 records): The leading hardware manufacturer on the register, representing pacemakers, surgical staplers, and advanced electro-cautery systems.
- Biomerieux SA (59 records): French diagnostics provider focused on microbiology systems and infectious disease test kits.
Local Applicant Channel Concentration: The Lock-In Effect
To register a medical device in Albania, a foreign manufacturer must appoint a local company to act as their Authorized Representative. This company submits the dossier to AKBPM and is recorded as the "Applicant" (emri_i_subjektit_qe_ka_kryer_aplikimin).
Our analysis of the 12,645 populated applicant rows reveals a highly concentrated channel. Out of 721 unique local applicants, the top 7 entities hold 3,388 registrations (26.8% of the populated applicant subset):
| Rank | Local Applicant / Representative | Registered Devices | Cumulative Share | Primary Focus |
|---|---|---|---|---|
| 1 | O.E.S DISTRIMED | 684 | 5.4% | Laboratory diagnostics, reagents, and clinical pathology |
| 2 | Pegasus Group (Pegasus, sh.p.k, PEGASUS.) | 664 | 5.3% | Advanced medical hardware, surgical implants, and radiology |
| 3 | GREEMED | 499 | 3.9% | Reusable instruments, disposable consumables, wound care |
| 4 | Evita (written as E v i t a) | 464 | 3.7% | Hemodialysis supplies, renal care, clinical consumables |
| 5 | TRIMED (written as T R I M E D) | 370 | 2.9% | Critical care systems, patient monitors, ventilators |
| 6 | MONTAL | 357 | 2.8% | Specialized dental implants, resins, and orthodontic supplies |
| 7 | BIOMETRIC ALBANIA | 350 | 2.8% | Molecular diagnostics, laboratory systems, reagents |
| Total | Top 7 Local Representatives | 3,388 | 26.8% | Over a quarter of the active market |
Albania Top Local Representative Share:
O.E.S DISTRIMED: [====================] 684
Pegasus Group: [===================] 664
GREEMED: [==============] 499
Evita: [=============] 464
TRIMED: [==========] 370
The Strategic Implication of Channel Concentration
This concentration represents a major "lock-in" effect. If a foreign manufacturer partners with one of these top 7 distributors, they gain access to a highly experienced regulatory team with established relationships at AKBPM. However, it also means these distributors hold substantial leverage during price negotiations.
Furthermore, under Albanian law, the registry listing is tied directly to the applicant's corporate license. If a manufacturer wishes to change their distributor mid-contract, they must secure a formal "Letter of No Objection" from the current representative to transfer the registrations. If the relationship has deteriorated, the current distributor can refuse, effectively locking the manufacturer out of the Albanian market until the 5-year registration expires and a new dossier is submitted under a new representative.
Language and Translation Compliance Gates in Albania
A major compliance area that frequently causes delays for foreign manufacturers is the translation of product documentation. Under Law No. 89/2014 and the implementing guidelines of Order No. 360, AKBPM enforces strict language policies:
- User Manuals and Instructions for Use (IFU): For any device intended for home use or self-testing by patients, the user manual, user interface (UI) software, and quick-start guides must be translated into Albanian. For clinical hardware used exclusively by trained healthcare professionals in hospitals (such as CT scanners or surgical lasers), AKBPM generally accepts IFUs in English, provided the local representative files a technical justification.
- Packaging and Labeling: The primary packaging label must feature key safety details in Albanian, including the product description, storage conditions, sterile status, and expiration warning. Machine-translated text is heavily audited; AKBPM has rejected submissions due to Google-translated medical terms that did not match local clinical nomenclature.
- The Translation Audit Risk: Local representatives often handle these translations. However, if the quality is poor, it can lead to immediate rejection during the completeness screening. Foreign manufacturers should mandate that all translations undergo a secondary review by a bilingual clinical specialist and require the local representative to provide notarized proof of translation accuracy.
Post-Market Surveillance (Vigilance) and Adverse Event Reporting for Albania
Maintaining an active registration with AKBPM requires adherence to the national vigilance system outlined in Law No. 89/2014:
- Reporting Timelines: The local representative must report any clinical incident involving a registered device that resulted in death or a serious deterioration of health to AKBPM within 10 calendar days. If the incident presents an immediate public health threat, the timeline is shortened to 48 hours.
- Field Safety Corrective Actions (FSCA): If a manufacturer issues a global product recall or safety warning, the Albanian representative must notify the AKBPM Vigilance Department within 24 hours of the global release. The LTR must submit the recall plan, trace all distributed units within Albanian clinics, and submit a final reconciliation report within 90 days showing that the affected units have been quarantined or destroyed.
- Vigilance Inspections: AKBPM reserves the right to audit local representatives' warehouses and compliance logs. If an LTR is found to have failed to report a clinical adverse event or is distributing unlisted variants, the agency can suspend the establishment's distribution licence, causing an immediate custom block on all the manufacturer's products.
Strategic Partner Selection and Negotiation Checklist for Albania
Given the high distributor concentration and the legal difficulties of transferring registrations, foreign manufacturers should follow this checklist when negotiating contracts in Albania:
- Establishment of Registration Ownership: The distribution contract should explicitly state that the local representative holds the AKBPM registration only as a custodian on behalf of the manufacturer, and that they must provide a pre-signed, undated "Letter of No Objection" to allow registration transfer at no cost upon contract termination.
- CE Mark Maintenance Clause: Bind the local distributor to maintain the registry listing in good standing, including the prompt submission of updated CE certificates to AKBPM to prevent automatic custom suspensions.
- Vigilance and Reporting Protocol: Clearly outline the workflow for adverse event reporting, ensuring that the local representative notifies the manufacturer of any complaints within 48 hours to meet global quality system standards.
- Apostille and Translation Timelines: Define which party covers the costs and handles translation of labelling and IFUs to Albanian, ensuring that all translations are audited by a bilingual clinical specialist.
Temporal Growth of the AKBPM Registry
By plotting the year of application (data_e_aplikimit) extracted from the database, we can trace the maturation of the registry:
- 2020: 158 registrations (First pilot electronic portal)
- 2021: 2,332 registrations (Compulsory transition to digital)
- 2022: 2,341 registrations (Post-pandemic catch-up)
- 2023: 2,158 registrations (Steady state approvals)
- 2024: 2,297 registrations (Registry expansion)
- 2025: 3,348 registrations (Massive digitized compliance push)
The surge in 2025 (3,348 registrations) represents the enforcement of digitized compliance. AKBPM began cross-referencing custom import sheets with the registry database, forcing local distributors to register any long-tail devices that had previously slipped through under generic categories.
Step-by-Step Registration Process in Albania
For a foreign manufacturer intending to register a CE-marked device in Albania, the process follows these phases:
- Prepare Technical Dossier and Translate: Compile the technical documentation, including Notified Body audit summaries, clinical evaluation reports, and Declaration of Conformity. Translate primary labels, patient instructions, and IFUs into Albanian.
- Appoint Local Representative: Appoint a licensed Albanian company to act as the Authorized Representative. The Power of Attorney (PoA) and Free Sale Certificate (FSC) must be notarized and apostilled.
- Submit Digital Dossier: The representative uploads the dossier and pays the submission fee via the
e-Albaniaportal (approximately €50 for Class I, €150 for Class IIa/IIb/III). - Completeness Screening: AKBPM evaluates the file for missing documents. If deficiencies are flagged, the representative has 15 days to upload the missing info.
- Scientific Committee Review: For Class III and active implantable devices, the dossier is forwarded to the AKBPM Scientific Committee, which reviews Notified Body credentials and clinical summaries.
- Certification and Import Clearance: Once approved, AKBPM issues a registration certificate valid for 5 years, allowing immediate importation.
Balkans Cross-Country Registry Comparison
How does Albania's registry structure compare with its regional neighbors in the Western Balkans? The table below maps these differences:
| Metric | Albania (AKBPM) | Serbia (ALIMS) | Montenegro (CINMED) | North Macedonia (MALMED) | Moldova (AMDM) |
|---|---|---|---|---|---|
| Total Register Size | 25,436 records | 57,153 records | 15,179 records | 5,223 records | 20,339 records |
| EU MDR Alignment | Reliance on CE Mark (Law 89/2014) | Transposed EU MDR (Law of 2017) | Transposed EU MDR (Law of 2020) | CE-reliance under Law of 2015 | CE-reliance under Law of 2017 |
| Metadata Completeness | ~50% populated | High (~95% populated) | High (~98% populated) | Moderate (~80% populated) | Moderate (~75% populated) |
| Local Representation | Mandatory Authorized Rep | Mandatory Local Representative | Mandatory Authorized Rep | Mandatory Authorized Rep | Mandatory Local Representative |
| Validity Cycle | 5 years | 5 years | 5 years | 5 years | 5 years |
| Primary Categories | Dental (15.1%), IVD (17.6%) | Cardiovascular, Orthopedic | Consumables, Oncology | Surgical consumables | Generic hospital lines |
At 25,436 records, Albania's register is the second-largest in the Western Balkans teardown set, behind Serbia (57,153) and ahead of the Moldova AMDM medical device registry teardown (20,339) and Montenegro (15,179) — though Albania's headline volume is inflated by the ~50% unpopulated metadata entries, so its populated dataset (12,637 records) is materially smaller than Serbia's or Moldova's. Albania does, however, exhibit the highest relative concentration of dental registrations, reflecting the country's localized medical tourism specialization.
FAQs
How many medical devices are registered with AKBPM in Albania?
The official national register contains 25,436 device records as of November 2025, though only 12,637 have active classification metadata.
Do I need a local authorised representative to register a medical device in Albania?
Yes. Foreign manufacturers must appoint a licensed Albanian company through an apostilled Power of Attorney to act as their local representative and submit the dossier.
Which local distributors hold the most AKBPM medical device registrations?
The channel is highly concentrated. The leading local applicants are O.E.S DISTRIMED (684 registrations), Pegasus Group (664), GREEMED (499), and Evita (464).
Is CE marking mandatory for medical devices in Albania?
Yes. Albania operates a CE-reliance system. To register any Class IIa, IIb, or III device, the manufacturer must submit a valid CE certificate issued by an EU Notified Body.
What happens if my representative refuses to sign a registration transfer?
The registration remains locked under their corporate license. You cannot import products through another distributor until the 5-year registration expires and you submit a completely new application.
References
- Law No. 89/2014 "On Medical Devices", Republic of Albania.
- Order No. 360 of 22.08.2016 on Procedures and Rules for Registration of Medical Devices, Ministry of Health, Albania.
- Order No. 734 of 18.10.2019 amending Order No. 360, Ministry of Health, Albania.
- Balkans MedTech Regulatory Profile & Registration Requirements, GlobalMedReg, 2025.
- Albania Medical Device Market Access & Representative Guidelines, OMC Medical, 2025.
- AKBPM National Register of Medical Devices (Regjistri i pajisjeve mjekësore), AKBPM Official Site.